Sincere Co. LTD.
TTSE:7782505.00
JPY
+1.00
(+0.20%)
ISIN
JP3376500009
Return %
Stock
S&P 500
1Y
-11.09
14.20
3Y
-3.26
81.12
5Y
-14.84
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Yasunori Yamamoto
- Full Time Employees
- 60
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Hongo MK Building Tokyo TY Japan 113-0033
- IPO Date
- Dec 16, 2016
- Website
- sincere-vision.com
- Similar Companies
- Business
- Sincere Co., Ltd. engages primarily in the manufacture and distribution of high-quality contact lenses, with a significant focus on medical contact lenses prescribed by ophthalmologists. Its product portfolio includes daily disposable lenses such as the flagship "Sincere One Day S" line, launched in 2019, along with color lenses targeted at both B2B OEM customers and retail markets. The company also provides comprehensive regulatory support services for medical devices, quasi-drugs, and cosmetics, especially assisting overseas manufacturers in obtaining approvals from Japan's Ministry of Health, Labour and Welfare. Sincere Co., Ltd. operates extensively within Japan and maintains partnerships across Asia, including China, Taiwan, and Korea, emphasizing both domestic market consolidation and strategic overseas expansion. In recent developments, Sincere Co., Ltd. has accelerated its contact lens business growth while strategically shifting towards strengthening its B2B OEM manufacturing model rather than competing directly in the increasingly crowded color lens retail market. The company also expanded its service offerings by enhancing consultation and regulatory advisory services for domestic and foreign contact lens manufacturers seeking entry into the Japanese market. Furthermore, Sincere emphasizes innovation in high-value-added products with enhanced profitability and has adopted new operational systems to reduce manpower reliance. These moves are part of its broader strategy to sustain competitive advantage and expand market share while managing currency exchange impacts and import logistics. Founded in 1969 and headquartered in Japan, Sincere Co., Ltd. operates within the medical devices and eye care industry segment. The company has developed a comprehensive sales distribution network that targets not only first-time contact lens users, ranging from children to the elderly via ophthalmologists, but also drugstore channels and inbound demand markets. Sincere's strategic alliances and ongoing partnerships across Asia underline its intent to build a robust global presence while maintaining its leadership in the Japanese medical lens market. Besides the core contact lens business, the company actively provides consulting services to facilitate regulatory and market entry for foreign companies in Japan, positioning itself as a key industry bridge and advisor. This dual focus on manufacturing and consultancy enhances its profile in a competitive market landscape, ensuring diversified revenue streams. The company’s fabless manufacturing model, leveraging partnerships with global factories, further supports its operational flexibility and cost efficiency. Overall, Sincere Co., Ltd. solidifies its reputation as a specialist in medical contact lenses and related regulatory services, leveraging innovation, strategic partnerships, and market expansion initiatives to maintain growth and profitability in the evolving eye care sector. These recent strategic changes have enabled it to navigate a competitive environment while building a sustainable business foundation.